Cargando...
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes
OBJECTIVE: To further evaluate the safety and efficacy of the Control-IQ closed-loop control (CLC) system in children with type 1 diabetes. RESEARCH DESIGN AND METHODS: After a 16-week randomized clinical trial (RCT) comparing CLC with sensor-augmented pump (SAP) therapy in 101 children 6–13 years o...
Guardado en:
| Publicado en: | Diabetes Care |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Diabetes Association
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7818334/ https://ncbi.nlm.nih.gov/pubmed/33355258 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1729 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|